Therapy

An statistical evaluation of 1480 tinnitus patients under study, (Bergmann-Bertora) quantitatively before and after treatment, allows us to state that 9% of cases did not show any improvement in symptoms or reasons on which consultation has been originated. In most cases, they are patients with personality disorders especially obsessive-compulsive type disorders (OCD) and other pathologies […]

Tinnitus Therapy schedule developed by us, we based on the schema of the auditory via and on the cortico -striatum- thalamus -cortical control system. The selected medicine or neurotransmitter will be directed to regulating the neuronal hyperactivity or hypoactivity functions, depending on the topographical location of tinnitus. It is impossible to treat tinnitus by a […]

Over the last 28 years the author has been fascinated with both Meniere’s disease and patients with perilymphatic fistula (PLF), two conditions which at times closely resemble each other and at times may be indistinguishable. Both conditions manifest themselves with vertigo, tinnitus, pressure or fullness and hearing fluctuation or loss. All of these entities may […]

We have been clinically treating vertigo patients for the last 45 years. As you all know vertigo is not a simple otolaryngorogic disease. In fact, it is associated with various diseases in various clinical fields including internal medicine, neurosurgery and ophthalmology. International Tinnitus Journal – ITJ, go to http://www.tinnitusjournal.com/ As an otolaryngorogist, we have learned […]

Persistent blurred vision and oscillopsia have negative impact on Quality of Life, and the burden of these symptoms is more severe than that of rotationally vertigoiginous attack. We, doctors, should take patient’s pain as our own and treat patients accordingly. However, because these cases are rather rare in daily clinical situation, in reality, we tend […]

Caroverine a quinoxaline derivative, with glutamate antagonistic activity was used for cochlear synaptic tinnitus. A pilot study was done first in 4 cases at our centre. Two cases with pure cochlear synaptic tinnitus responded well to Caroverine while other two cases had tinnitus due to middle ear pathology and did not respond. Encouraged by these […]

Objective/Hypothesis: The purpose of this study is to assess the efficacy of hydroxyethyl starch (HES 200) in the treatment of sudden deafness of vascular origin, and compare it with that of dextran 40. Study Design: Prospective study Methods: Ten patients with sudden deafness of vascular origin undergoing HES 200 therapy with the treatment program as […]

The AIM of this investigation is to evaluate the effect of Betaserc – 16 and 8 mg on the patients (workers in the system of transport), with vascular auditory and vestibular disturbances.

Our goal was to attempt to establish neuropharmacological tinnitus control (i.e., relief) with medication directed to restoration of a deficiency in the g-aminobutyric acid – benzodiazepine – chloride receptor in tinnitus patients with a diagnosis of a predominantly central type tinnitus.

We carried out a retrospective survey of 25 years of clinical experience with the use of clonazepam as a vestibular and tinnitus suppressant in the pharmacological treatment of vestibular or cochleovestibular disorders due to different causes.